These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7646188)

  • 1. The hybrid xenograft/autograft bioprosthetic heart valve: in vivo evaluation of tissue extraction.
    Vesely I; Noseworthy R; Pringle G
    Ann Thorac Surg; 1995 Aug; 60(2 Suppl):S359-64. PubMed ID: 7646188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
    Simionescu DT; Lovekamp JJ; Vyavahare NR
    J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism.
    Levy RJ; Vyavahare N; Ogle M; Ashworth P; Bianco R; Schoen FJ
    J Heart Valve Dis; 2003 Mar; 12(2):209-16; discussion 216. PubMed ID: 12701794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kangaroo versus porcine aortic valve tissue--valve geometry morphology, tensile strength and calcification potential.
    Neethling WM; Papadimitriou JM; Swarts E; Hodge AJ
    J Cardiovasc Surg (Torino); 2000 Jun; 41(3):341-8. PubMed ID: 10952321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No-react detoxification process: a superior anticalcification method for bioprostheses.
    Abolhoda A; Yu S; Oyarzun JR; Allen KR; McCormick JR; Han S; Kemp FW; Bogden JD; Lu Q; Gabbay S
    Ann Thorac Surg; 1996 Dec; 62(6):1724-30. PubMed ID: 8957377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcification resistance with aluminum-ethanol treated porcine aortic valve bioprostheses in juvenile sheep.
    Ogle MF; Kelly SJ; Bianco RW; Levy RJ
    Ann Thorac Surg; 2003 Apr; 75(4):1267-73. PubMed ID: 12683574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional distribution of calcification in aortic valve cusps. An in vivo study.
    Mako WJ; Vesely I
    ASAIO J; 1996; 42(5):M365-7. PubMed ID: 8944908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves.
    Chen W; Schoen FJ; Levy RJ
    Circulation; 1994 Jul; 90(1):323-9. PubMed ID: 8026014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralization of glutaraldehyde-fixed porcine aortic valve cusps in the subcutaneous rat model: analysis of variations in implant site and cuspal quadrants.
    Mako WJ; Shah A; Vesely I
    J Biomed Mater Res; 1999 Jun; 45(3):209-13. PubMed ID: 10397978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation.
    O'Brien MF; Goldstein S; Walsh S; Black KS; Elkins R; Clarke D
    Semin Thorac Cardiovasc Surg; 1999 Oct; 11(4 Suppl 1):194-200. PubMed ID: 10660192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential.
    Pathak CP; Adams AK; Simpson T; Phillips RE; Moore MA
    J Biomed Mater Res A; 2004 Apr; 69(1):140-4. PubMed ID: 14999761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study.
    Simionescu DT; Lovekamp JJ; Vyavahare NR
    J Heart Valve Dis; 2003 Mar; 12(2):226-34. PubMed ID: 12701796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations.
    Levy RJ; Schoen FJ; Flowers WB; Staelin ST
    J Biomed Mater Res; 1991 Aug; 25(8):905-35. PubMed ID: 1918108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection.
    Manji RA; Zhu LF; Nijjar NK; Rayner DC; Korbutt GS; Churchill TA; Rajotte RV; Koshal A; Ross DB
    Circulation; 2006 Jul; 114(4):318-27. PubMed ID: 16831988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo.
    Liu Y; Liu W; Sun G; Wei X; Yi D
    Heart Surg Forum; 2009 Jan; 12(1):E24-9. PubMed ID: 19233761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin attenuates bioprosthetic heart valve calcification.
    Lee S; Kim DH; Youn YN; Joo HC; Yoo KJ; Lee SH
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):731-741.e1. PubMed ID: 30738596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preimplant ultrastructure and calcification tendency of various biological aortic valves.
    Mirzaie M; Meyer T; Schwartz P; Dalichau H
    J Heart Valve Dis; 2000 Jul; 9(4):576-82. PubMed ID: 10947053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amide cross-linking: an alternative to glutaraldehyde fixation.
    Girardot JM; Girardot MN
    J Heart Valve Dis; 1996 Sep; 5(5):518-25. PubMed ID: 8894992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reactions.
    Gong G; Seifter E; Lyman WD; Factor SM; Blau S; Frater RW
    J Heart Valve Dis; 1993 Nov; 2(6):684-93. PubMed ID: 7719511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Integrity Preservation Technology Reduces Bioprosthesis Calcification While Preserving Performance and Safety.
    De La Fuente AB; Wright GA; Olin JM; Duhay FG; Kapelak B; Bochenek M; Bartus K; Sadowski J
    J Heart Valve Dis; 2015 Jan; 24(1):101-9. PubMed ID: 26182627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.